Ipamorelin 5 mg/Tesamorelin 5 mg

Dragon Pharma Ipamorelin/Tesamorelin Blend

For athletes, bodybuilders, and fitness enthusiasts seeking optimal recovery, lean muscle preservation, and improved body composition, growth hormone modulation is a cornerstone of advanced research. Ipamorelin (a selective GHRP) and Tesamorelin (a potent GHRH analog) represent two of the most studied growth hormone secretagogues, each with distinct yet complementary mechanisms. When combined, they create a powerful synergistic effect that stimulates robust, pulsatile growth hormone release while maintaining a favorable side effect profile. This Dragon Pharma Ipamorelin/Tesamorelin 5mg blend offers a convenient pre-mixed formulation with 5mg of each peptide in a single lyophilized vial, providing researchers with a comprehensive tool for advanced growth hormone research.

Ipamorelin functions as a selective growth hormone-releasing peptide (GHRP) that acts on the ghrelin receptor, stimulating GH release with minimal effects on cortisol, prolactin, and appetite—making it ideal for long-term research protocols. Tesamorelin is a potent growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary to release GH in a physiological pulsatile manner. Clinical research published in the NIH PubMed database demonstrates that Tesamorelin has been extensively studied for its effects on visceral adipose tissue reduction, while the combination of a GHRH analog with a GHRP produces a synergistic GH response significantly greater than either compound alone.

The relevance of this blend to the athletic and bodybuilding community is substantial. Growth hormone plays a critical role in protein synthesis, collagen formation, lipolysis, and immune function. The Ipamorelin/Tesamorelin combination supports enhanced recovery from intense training, improved sleep architecture, better preservation of lean muscle mass during caloric deficits, and accelerated repair of connective tissue. Notably, Tesamorelin has been specifically studied for its ability to reduce visceral adipose tissue—the deep abdominal fat associated with metabolic dysfunction—making it particularly valuable for athletes focused on body composition and metabolic health. Ipamorelin's clean side effect profile complements Tesamorelin's potent GH-releasing effects, creating a balanced research tool.

Quality assurance is paramount in peptide research. Each batch of our Ipamorelin/Tesamorelin inventory undergoes rigorous third-party HPLC-MS testing to verify purity and dosage. The most recent batch (November 2025) tested at 5.47 mg of Ipamorelin and 5.33 mg of Tesamorelin with batch number #HDIT10, demonstrating Dragon Pharma's commitment to quality and consistency. This level of transparency ensures that researchers can trust the integrity of the compounds they are investigating.

For bodybuilders and strength athletes navigating the demands of intense training cycles, the Ipamorelin/Tesamorelin blend offers a sophisticated research tool for supporting growth hormone pathways with a focus on body composition. The pre-mixed formulation eliminates the need to reconstitute two separate vials, simplifying research protocols and ensuring consistent ratios. Whether investigating strategies for accelerated recovery, visceral fat reduction, or lean muscle preservation, Dragon Pharma's Ipamorelin/Tesamorelin blend delivers the purity, potency, and reliability required for serious research into growth hormone modulation.

Note: This product is intended for laboratory research and scientific investigation purposes only. Not for human consumption or veterinary use.

Product Specifications

Usage Guidelines

This Ipamorelin/Tesamorelin blend is supplied as a sterile lyophilized powder and must be reconstituted with bacteriostatic water prior to research use. For optimal stability, gently swirl the vial after adding the diluent—do not shake vigorously. Standard research protocols involve reconstituting the 10mg blend (5mg each) with 2-4mL of bacteriostatic water, yielding a concentration of 2.5-5mg/mL total peptide (1.25-2.5mg/mL of each peptide). Typical research dosing for this blend ranges from 200-500mcg of each peptide per administration (400-1000mcg total), often administered 1-2 times daily via subcutaneous injection. For optimal GH pulsatility, administer on an empty stomach, waiting at least 2 hours after meals and 30 minutes before eating. It is recommended to store the reconstituted peptide in a refrigerator (2-8°C) and use within 30 days to maintain peptide integrity.

For researchers investigating comprehensive growth hormone modulation and body composition protocols, combining this blend with complementary compounds can yield synergistic insights. Consider exploring the following Dragon Pharma products to enhance your research:

• CJC-1295 Dac: A long-acting GHRH analog for comparative research on pulsatile vs. sustained GH elevation.
• IGF-1 LR3: An insulin-like growth factor for research on downstream anabolic pathways.
• MK 677: An oral growth hormone secretagogue for comparative research on GH elevation mechanisms.

Third-Party Lab Results

2025-11-10

View Certificate

5.47 mg / 5.33 mg

Shipping & Authenticity

• From USA Domestic warehouse: 2-5 business days.
• From International warehouse: 14-21 business days.
• Free and automatic re-shipping policy if package doesn't reach destination within 30 days.
• Original product directly from manufacturer.
• We accept credit cards and cryptocurrency—crypto payments receive an additional 20% discount at checkout.

Storage Instructions

To maintain maximum stability and potency of the lyophilized powder, store the unopened vial in a freezer at -20°C (-4°F) away from light. Upon reconstitution with bacteriostatic water, the solution must be stored in a refrigerator at 2-8°C (36-46°F) and should be used within 30 days. Avoid repeated freeze-thaw cycles as this may degrade the peptide structure.

Frequently Asked Questions